BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 38009192)

  • 1. LINC01140 Hinders the Development of Breast Cancer Through Targeting miR-200b-3p to Downregulate DMD.
    Peng G; Yan J; Shi P; Li H
    Cell Transplant; 2023; 32():9636897231211202. PubMed ID: 38009192
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circ_0,007,331 Promotes the PTX Resistance and Progression of Breast Cancer via miR-200b-3p/ANLN.
    Yang C; Liu L; Gao C; Zhang G; Zhang Y; Zhang S; Li J; Liu Y
    J Surg Res; 2022 Nov; 279():619-632. PubMed ID: 35926312
    [TBL] [Abstract][Full Text] [Related]  

  • 3. LINC01140 Targeting miR-452-5p/RGS2 Pathway to Attenuate Breast Cancer Tumorigenesis.
    Li X
    Dis Markers; 2022; 2022():2434938. PubMed ID: 36299824
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNA-200b-3p restrains gastric cancer cell proliferation, migration, and invasion via C-X-C motif chemokine ligand 12/CXC chemokine receptor 7 axis.
    Li D; Li Q
    Bioengineered; 2022 Mar; 13(3):6509-6520. PubMed ID: 35226830
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exosome-Mediated lncRNA LINC01140 Attenuates Breast Cancer Progression by Regulating the Wnt/β-Catenin Pathway.
    Guo Z; Li Y; Li W; Li H; Wu Z
    Crit Rev Eukaryot Gene Expr; 2023; 33(7):31-42. PubMed ID: 37602451
    [TBL] [Abstract][Full Text] [Related]  

  • 6. LINC00667 Promotes Progression of Esophageal Cancer Cells by Regulating miR-200b-3p/SLC2A3 Axis.
    Pan J; Zang Y
    Dig Dis Sci; 2022 Jul; 67(7):2936-2947. PubMed ID: 34313922
    [TBL] [Abstract][Full Text] [Related]  

  • 7. LncRNA LINC01140 Inhibits Glioma Cell Migration and Invasion via Modulation of miR-199a-3p/ZHX1 Axis.
    Xin Y; Zhang W; Mao C; Li J; Liu X; Zhao J; Xue J; Li J; Ren Y
    Onco Targets Ther; 2020; 13():1833-1844. PubMed ID: 32184618
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Circ_0008039 supports breast cancer cell proliferation, migration, invasion, and glycolysis by regulating the miR-140-3p/SKA2 axis.
    Dou D; Ren X; Han M; Xu X; Ge X; Gu Y; Wang X; Zhao S
    Mol Oncol; 2021 Feb; 15(2):697-709. PubMed ID: 33244865
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MiR-200b expression in breast cancer: a prognostic marker and act on cell proliferation and apoptosis by targeting Sp1.
    Yao Y; Hu J; Shen Z; Yao R; Liu S; Li Y; Cong H; Wang X; Qiu W; Yue L
    J Cell Mol Med; 2015 Apr; 19(4):760-9. PubMed ID: 25639535
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of lncRNA TRPM2-AS/miR-140-3p/PYCR1 axis's proliferates and anti-apoptotic effect on breast cancer using co-expression network analysis.
    Sun T; Song Y; Yu H; Luo X
    Cancer Biol Ther; 2019; 20(6):760-773. PubMed ID: 30810442
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNA-409-3p regulates cell invasion and metastasis by targeting ZEB1 in breast cancer.
    Ma Z; Li Y; Xu J; Ren Q; Yao J; Tian X
    IUBMB Life; 2016 May; 68(5):394-402. PubMed ID: 27079864
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Disruption of the c-Myc/miR-200b-3p/PRDX2 regulatory loop enhances tumor metastasis and chemotherapeutic resistance in colorectal cancer.
    Lv Z; Wei J; You W; Wang R; Shang J; Xiong Y; Yang H; Yang X; Fu Z
    J Transl Med; 2017 Dec; 15(1):257. PubMed ID: 29258530
    [TBL] [Abstract][Full Text] [Related]  

  • 13. KCNQ1OT1 mediates keratinocyte migration to promote skin wound healing through the miR-200b-3p/SERP1 axis.
    Huang W; Chen J; Xu E; Zhu T; Cai X
    Burns; 2023 Mar; 49(2):415-424. PubMed ID: 35523657
    [TBL] [Abstract][Full Text] [Related]  

  • 14. LINC01140 inhibits nonsmall cell lung cancer progression and cisplatin resistance through the miR-4742-5p/TACC1 axis.
    Wang Y; Li M; Zhang L; Chen Y; Ha M
    J Biochem Mol Toxicol; 2022 Jul; 36(7):e23048. PubMed ID: 35307914
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circ_0000033 up-regulates NUAK2 by sequestering miR-378a-3p to promote breast tumorigenesis.
    Dai Y; Shi W; Qiu Y; Xu T; Lin J; Su Y
    Environ Mol Mutagen; 2023 Jul; 64(6):359-370. PubMed ID: 37357410
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Circ_PRDM5/miR-25-3p/ANKRD46 axis is associated with cell malignant behaviors in subjects with breast cancer evaluated by ultrasound.
    Lu Q; Sun H; Yu Q; Tang D
    J Biochem Mol Toxicol; 2023 Nov; 37(11):e23469. PubMed ID: 37485755
    [TBL] [Abstract][Full Text] [Related]  

  • 17. LncRNA XIST promotes liver cancer progression by acting as a molecular sponge of miR-200b-3p to regulate ZEB1/2 expression.
    Liu L; Jiang H; Pan H; Zhu X
    J Int Med Res; 2021 May; 49(5):3000605211016211. PubMed ID: 34018840
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Knockdown of circADAM9 inhibits cell progression and glycolysis by targeting the miR-1236-3p/FGF7 axis in breast cancer.
    Huang B; Zhang Y; Sun P; Lin J; Wang C
    Thorac Cancer; 2023 Aug; 14(24):2350-2360. PubMed ID: 37385973
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circ_ZFR affects FABP7 expression to regulate breast cancer progression by acting as a sponge for miR-223-3p.
    Tian X; Yang H; Fang Q; Quan H; Lu H; Wang X
    Thorac Cancer; 2022 May; 13(9):1369-1380. PubMed ID: 35355424
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circular RNA hsa_circ_0043278 inhibits breast cancer progression via the miR-455-3p/EI24 signalling pathway.
    Shi Y; Liu C
    BMC Cancer; 2021 Nov; 21(1):1249. PubMed ID: 34800978
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.